Related Experiment Video
Updated: Aug 8, 2025

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Higher HbA1c variability is associated with increased arterial stiffness in individuals with type 1 diabetes
Anniina Tynjälä1,2,3, Valma Harjutsalo1,2,3, Fanny Jansson Sigfrids1,2,3
1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Insights
Glycaemic variability, measured by HbA1c metrics, is linked to arterial stiffness in type 1 diabetes patients. This association persists independently of average blood glucose levels, highlighting variability as a key cardiovascular risk factor.
Area of Science:
- Cardiovascular Research
- Endocrinology
- Diabetes Mellitus
Background:
- Long-term glycaemic variability and arterial stiffness are recognized cardiovascular risk factors.
- Type 1 diabetes (T1D) management aims to mitigate cardiovascular complications.
- Understanding the interplay between glycaemic control and vascular health in T1D is crucial.
Purpose of the Study:
- To investigate the association between long-term glycaemic variability and arterial stiffness in adults with type 1 diabetes.
- To determine if this association is independent of mean HbA1c levels.
- To explore different metrics of glycaemic variability.
Main Methods:
- Cross-sectional study of 673 adults with type 1 diabetes.
- Retrospective analysis of 10-year HbA1c data to calculate variability indices (adj-HbA1c-SD, HbA1c-CV, HbA1c-ARV).
- Assessment of arterial stiffness using carotid-femoral pulse wave velocity (cfPWV) and augmentation index (AIx).
Main Results:
- All three HbA1c variability indices significantly correlated with cfPWV and AIx (p < 0.001).
- Adjusted HbA1c-SD and HbA1c-CV remained significantly associated with cfPWV and AIx (p < 0.05), even after adjusting for mean HbA1c.
- HbA1c-ARV showed no significant association in fully adjusted models.
Conclusions:
- An association exists between glycaemic variability and arterial stiffness in type 1 diabetes, independent of mean HbA1c.
- Multiple HbA1c variability metrics should be considered when assessing cardiovascular risk in T1D.
- Further longitudinal and interventional studies are needed to confirm causality and develop management strategies.
Background:
Both long-term glycaemic variability and arterial stiffness have been recognized as cardiovascular risk factors. This study aims to investigate whether an association between these phenomena exists in individuals with type 1 diabetes.
Methods:
This cross-sectional study included 673 adults (305 men, 368 women) with type 1 diabetes and combined available retrospective laboratory data on HbA1c from the preceding 10 years with outcome data on arterial stiffness and clinical variables from a comprehensive study visit. HbA1c variability was calculated as adjusted standard deviation (adj-HbA1c-SD), coefficient of variation (HbA1c-CV) and average real variability (HbA1c-ARV). As measures of arterial stiffness, carotid-femoral pulse wave velocity (cfPWV; n = 335) and augmentation index (AIx; n = 653) were assessed using applanation tonometry.
Results:
The study population had a mean age of 47.1 (± 12.0) years and a median duration of diabetes of 31.2 (21.2-41.3) years. The median number of HbA1c assessments per individual was 17 (12-26). All three indices of HbA1c variability were significantly correlated with both cfPWV and AIx after adjustment for sex and age (p < 0.001). In separate multivariable linear regression models, adj-HbA1c-SD and HbA1c-CV were significantly associated with cfPWV (p = 0.032 and p = 0.046, respectively) and AIx (p = 0.028 and p = 0.049, respectively), even after adjustment for HbA1c-mean. HbA1c-ARV was not associated with cfPWV or AIx in the fully adjusted models.
Conclusions:
An association independent of HbA1c-mean was found between HbA1c variability and arterial stiffness, suggesting a need to consider multiple HbA1c metrics in studies assessing cardiovascular risk in type 1 diabetes. Longitudinal and interventional studies are needed to confirm any causal relationship and to find strategies for reducing long-term glycaemic variability.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
10:35Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
Related Concept Videos
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Peripheral Artery Disease I: Introduction